Literature DB >> 10022442

Central administration of leptin inhibits food intake and activates the sympathetic nervous system in rhesus macaques.

M Tang-Christensen1, P J Havel, R R Jacobs, P J Larsen, J L Cameron.   

Abstract

The present study was performed to determine the effects of central administration of leptin on food intake and sympathetic nervous system activity in a nonrodent species, the rhesus monkey. Peripheral administration of leptin at doses (1 and 3 microg/kg, s.c.) that produced increments of circulating leptin concentrations within a physiological range did not inhibit food intake over the subsequent 3 days. In contrast, leptin (1 microg/kg, intracerebroventricularly) had no acute effect on food intake, but caused a significant and sustained suppression (40-50%) of food intake during the entire following day (P < 0.01). In addition, circulating norepinephrine levels increased by 55 +/- 16% (P < 0.02) 1 h after intracerebroventricular leptin administration, but did not increase after artificial cerebrospinal fluid administration. These results indicate that leptin can provide a signal to the central nervous system that decreases food intake in primates and in addition acutely activates the sympathetic nervous system. However, the results showing an acute increase in circulating leptin concentrations after peripheral administration of human leptin suggest that in primates, increases in circulating leptin within the physiological range do not acutely regulate food intake. Leptin may be more important in regulating food intake when there are sustained changes in circulating concentrations of leptin (e.g. with obesity, prolonged energy restriction, or diabetes).

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10022442     DOI: 10.1210/jcem.84.2.5458

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  33 in total

1.  Direct regulation of the proglucagon gene by insulin, leptin, and cAMP in embryonic versus adult hypothalamic neurons.

Authors:  Prasad S Dalvi; Frederick D Erbiceanu; David M Irwin; Denise D Belsham
Journal:  Mol Endocrinol       Date:  2012-06-05

Review 2.  Glucagon-like peptide 1 interacts with ghrelin and leptin to regulate glucose metabolism and food intake through vagal afferent neuron signaling.

Authors:  Charlotte C Ronveaux; Daniel Tomé; Helen E Raybould
Journal:  J Nutr       Date:  2015-02-04       Impact factor: 4.798

3.  Phosphodiesterase-3B is expressed in proopiomelanocortin and neuropeptide Y neurons in the mouse hypothalamus.

Authors:  Maitrayee Sahu; David G Litvin; Abhiram Sahu
Journal:  Neurosci Lett       Date:  2011-10-06       Impact factor: 3.046

4.  Low-dose leptin reverses skeletal muscle, autonomic, and neuroendocrine adaptations to maintenance of reduced weight.

Authors:  Michael Rosenbaum; Rochelle Goldsmith; Daniel Bloomfield; Anthony Magnano; Louis Weimer; Steven Heymsfield; Dympna Gallagher; Laurel Mayer; Ellen Murphy; Rudolph L Leibel
Journal:  J Clin Invest       Date:  2005-12       Impact factor: 14.808

5.  Dose-related steady states of fat loss in long-term leptin-treated ob/ob mice: leptin resistance or desensitization versus counterregulatory signaling.

Authors:  Sandra Eiden; Eckhart Simon; Ingrid Schmidt
Journal:  J Comp Physiol B       Date:  2005-10-26       Impact factor: 2.200

6.  A role of phosphodiesterase-3B pathway in mediating leptin action on proopiomelanocortin and neurotensin neurons in the hypothalamus.

Authors:  Abhiram Sahu
Journal:  Neurosci Lett       Date:  2010-05-13       Impact factor: 3.046

7.  Fructose-fed rhesus monkeys: a nonhuman primate model of insulin resistance, metabolic syndrome, and type 2 diabetes.

Authors:  Andrew A Bremer; Kimber L Stanhope; James L Graham; Bethany P Cummings; Wenli Wang; Benjamin R Saville; Peter J Havel
Journal:  Clin Transl Sci       Date:  2011-08       Impact factor: 4.689

Review 8.  Hypothalamic control of energy and glucose metabolism.

Authors:  Stephanie Sisley; Darleen Sandoval
Journal:  Rev Endocr Metab Disord       Date:  2011-09       Impact factor: 6.514

Review 9.  Use and Importance of Nonhuman Primates in Metabolic Disease Research: Current State of the Field.

Authors:  Peter J Havel; Paul Kievit; Anthony G Comuzzie; Andrew A Bremer
Journal:  ILAR J       Date:  2017-12-01

10.  Serum leptin levels following acute experimental spinal cord injury.

Authors:  Ali Riza Gezici; Ruchan Ergun; Alper Karakas; Bulent Gunduz
Journal:  J Spinal Cord Med       Date:  2009       Impact factor: 1.985

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.